InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (13 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
13
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Rolph Timothy, Chief Scientific Officer. Officer active across 1 company, notably Akero Therapeutics, Inc.. In total, 44 filings have been logged. Split: 0 buy · 13 sells. Total volume traded: €1.2m. Activity tracked since 30 June 2022. The latest transaction was filed on 25 November 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Rolph Timothy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations44 total
238,339 sharesCommon StockSEC:0001193125-25-312116:0
43,810 sharesCommon StockSEC:0001193125-25-312116:1
3,527 shares@ US$28.352.0% of flowCommon StockSEC:0001193125-25-301155:0
37,100 shares0Common StockSEC:0001193125-25-288555:0
12,500 shares@ US$28.357.1% of flowCommon StockSEC:0001193125-25-236152:0
553 shares@ US$43.020.5% of flowCommon StockSEC:0000950170-25-114662:0
7,044 shares@ US$21.093.2% of flowCommon StockSEC:0001779479-25-000007:0
12,500 shares@ US$21.095.9% of flowCommon StockSEC:0000950170-25-104623:0
12,500 shares@ US$21.096.2% of flowCommon StockSEC:0000950170-25-094882:0
890 shares@ US$23.8680.5% of flowCommon StockSEC:0000950170-25-093318:0
1,129 shares@ US$54.841.6% of flowCommon StockSEC:0000950170-25-088638:0
2,358 shares@ US$53.9963.3% of flowCommon StockSEC:0000950170-25-085673:0
12,500 shares@ US$21.106.9% of flowCommon StockSEC:0000950170-25-083878:0
12,500 shares@ US$21.107.8% of flowCommon StockSEC:0000950170-25-067381:0
6,250 shares@ US$21.103.9% of flowCommon StockSEC:0000950170-25-059449:0
6,250 shares@ US$21.104.0% of flowCommon StockSEC:0000950170-25-052956:0
516 shares@ US$44.880.7% of flowCommon StockSEC:0000950170-25-039731:0
12,500 shares@ US$21.108.3% of flowCommon StockSEC:0000950170-25-035709:0
18,750 shares@ US$21.1012.8% of flowCommon StockSEC:0000950170-25-016493:0
14,986 shares@ US$19.879.5% of flowCommon StockSEC:0000950170-25-010707:0
14,000 shares0Common StockSEC:0000950170-25-004425:0
14,100 shares0Common StockSEC:0000950170-24-141259:0
3,800 shares@ US$19.872.4% of flowCommon StockSEC:0000950170-24-138134:0
2,368 shares@ US$30.792.3% of flowCommon StockSEC:0000950170-24-136025:0
537 shares@ US$26.180.4% of flowCommon StockSEC:0000950170-24-106458:0
25 of 44 declarations
About Rolph Timothy
Rolph Timothy is Chief Scientific Officer at Akero Therapeutics, Inc. He has filed 44 forms in total, and across the recent filings covered from 2022-09-13 to 2025-12-09, buys total 0 EUR and sells total 1210235 EUR, with Levée d'options as the most frequent transaction nature.
